← back to search

Stephan R. Vavricka

Immunologie-Zentrum Zürich ·
Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Autoimmune and Inflammatory Disorders, and Eosinophilic Esophagitis.
h-index
69
citations
25,626
works
451
NIH funding
primary concept
email

Recent publications

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1
Journal of Crohn s and Colitis 2025cited by 60position: middledoi
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2
Journal of Crohn s and Colitis 2025cited by 25position: middledoi
International Magnetic Resonance Imaging Consensus for Use in Luminal Crohn’s Disease Trials and Clinical Practice
Clinical Gastroenterology and Hepatology 2025cited by 2position: middledoi
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials
Journal of Crohn s and Colitis 2025cited by 2position: middledoi
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Journal of Crohn s and Colitis 2024cited by 289position: middledoi
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
Journal of Crohn s and Colitis 2024cited by 130position: middledoi
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease
Journal of Crohn s and Colitis 2023cited by 255position: middledoi
Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies
Nature Reviews Rheumatology 2023cited by 34position: middledoi
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study
Journal of Clinical Medicine 2023cited by 6position: middledoi
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
Journal of Crohn s and Colitis 2022cited by 283position: middledoi
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases
˜The œLancet. Gastroenterology & hepatology 2022cited by 34position: middledoi
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
Therapeutic Advances in Gastroenterology 2021cited by 35position: middledoi
Emerging treatment options for extraintestinal manifestations in IBD
Gut 2020cited by 98position: lastdoi
Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea With Enterococcus faecium SF68
Frontiers in Medicine 2020cited by 47position: lastdoi
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series
Journal of Crohn s and Colitis 2020cited by 45position: middledoi
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement
Angiology 2020cited by 29position: middledoi
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Journal of Crohn s and Colitis 2019cited by 1,326position: middledoi
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
Journal of Crohn s and Colitis 2019cited by 1,113position: middledoi
Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus
Digestive Diseases 2019cited by 97position: middledoi
Perioperative Dietary Therapy in Inflammatory Bowel Disease
Journal of Crohn s and Colitis 2019cited by 92position: middledoi
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients
Journal of Crohn s and Colitis 2019cited by 39position: middledoi
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Journal of Crohn s and Colitis 2018cited by 1,803position: middledoi
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
Journal of Crohn s and Colitis 2018cited by 448position: middledoi
Environmental triggers in IBD: a review of progress and evidence
Nature Reviews Gastroenterology & Hepatology 2017cited by 924position: middledoi
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Journal of Crohn s and Colitis 2016cited by 2,059position: middledoi
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort
Inflammatory Intestinal Diseases 2016cited by 18position: middledoi
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Journal of Crohn s and Colitis 2015cited by 798position: middledoi
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort
Inflammatory Bowel Diseases 2015cited by 272position: firstdoi
Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries
Inflammatory Bowel Diseases 2014cited by 160position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Péter L. Lakatos · University Gastroenterology4 papers (2015–2020)Laurent Peyrin‐Biroulet · Hôpital Lapeyronie4 papers (2015–2020)Torsten Kucharzik · Leuphana University of Lüneburg3 papers (2016–2020)Thomas Greuter · University of Lausanne3 papers (2020–2021)Ioannis E. Κoutroubakis · University of Crete3 papers (2014–2020)Κωνσταντίνος Κατσάνος · University Hospital of Ioannina3 papers (2019–2020)Alain Schoepfer · Swiss HIV Cohort Study2 papers (2015–2020)Florian Rieder · Cleveland Clinic2 papers (2016–2020)Paulo Gustavo Kotze · Hospital Ortopédico de Passo Fundo2 papers (2019–2021)Vito Annese · Vita-Salute San Raffaele University2 papers (2015–2016)Pascal Juillerat · Clinique de La Source2 papers (2015–2016)Silvio Danese · Io Therapeutics (United States)2 papers (2019–2020)Matthieu Allez · Inserm2 papers (2015–2019)David T. Rubin · University of California System2 papers (2020–2021)Herbert Tilg · University Hospital Innsbruck2 papers (2015–2016)Gerhard Rogler · University College London2 papers (2015–2016)Alessandro Armuzzi · Fondazione Humanitas per la Ricerca2 papers (2016–2023)Edoardo Savarino · Amsterdam University Medical Centers2 papers (2023–2023)Uri Kopylov · Tel Aviv University2 papers (2020–2023)Paolo Gionchetti · Istituti di Ricovero e Cura a Carattere Scientifico2 papers (2016–2020)